CLINICAL_TRIALS
trial_result
· 2012-03-13
Clinical Trial Update: Study of Daclizumab in Patients With Chronic, Persistent Asthma [Phase 2]
Summary
A completed Phase 2 clinical trial evaluating daclizumab in adults with chronic, persistent asthma was reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Facet Biotech | Conditions: Asthma | Phase 2 | Status: COMPLETED